Why Nature's Sunshine (NATR) shares are plunging today

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

NATR Cover Image

What happened?

Shares of wellness products company Nature’s Sunshine (NASDAQ: NATR) fell 21.9% in the morning session after the company reported third-quarter 2026 financial results showing a 9% decline in net sales alongside shrinking profit margins. 

According to a company press release, Nature's Sunshine reported that net sales fell to $116.6 million for the period ended September 30, 2026, compared to $128.3 million in the prior-year period. Its gross profit margin contracted by 42 basis points, while GAAP net income attributable to common shareholders was $1.9 million and adjusted EBITDA was $11.1 million. 

Additionally, the company lowered its full-year revenue guidance to $465 million at the midpoint from $495 million, representing a 6.1% decrease.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Nature's Sunshine? Access our full analysis report here, it’s free.

What is the market telling us

Nature's Sunshine’s shares are somewhat volatile and have had 10 moves greater than 5% over the last year. But moves this big are rare even for Nature's Sunshine and indicate this news significantly impacted the market’s perception of the business.

The biggest move we wrote about over the last year was 12 months ago when the stock gained 26.3% on the news that the company reported strong third-quarter 2025 results that beat Wall Street's expectations and raised its full-year guidance. 

The wellness products company announced that its sales increased 12% year-over-year to $128.3 million, topping analyst estimates. Profitability also saw a significant boost, with adjusted earnings of $0.36 per share, more than double Wall Street's forecast of $0.16. The company's operational efficiency improved, with its operating margin expanding to 7% from 4.6% in the same quarter last year. In light of these positive results, Nature's Sunshine lifted its full-year 2025 forecast for both sales and adjusted EBITDA, signaling confidence in its continued business momentum.

Nature's Sunshine is down 52.4% since the beginning of the year, and at $10.07 per share, it is trading 63.8% below its 52-week high of $27.80 from March 2026. Investors who bought $1,000 worth of Nature's Sunshine’s shares 5 years ago would now be looking at only $579.27.

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  260.34
-5.69 (-2.14%)
AAPL  346.41
-3.10 (-0.89%)
AMD  421.90
-66.88 (-13.68%)
BAC  50.58
-1.05 (-2.04%)
GOOG  283.54
-3.76 (-1.31%)
META  609.47
-20.53 (-3.26%)
MSFT  541.22
-14.58 (-2.62%)
NVDA  186.95
-13.18 (-6.59%)
ORCL  114.44
-9.29 (-7.50%)
TSLA  350.29
-34.90 (-9.06%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.